Cytek Biosciences (CTKB) Goodwill (2020 - 2026)

Cytek Biosciences has reported Goodwill for 7 years, with the latest figure at $16.7 million in Q1 2026.

• For the quarter ending Q1 2026, Goodwill changed 0.07% year-over-year to $16.7 million; the trailing twelve-month figure through Mar 2026 stood at $16.7 million (changed 0.07% YoY), and the FY2025 full-year result was $16.7 million, changed 0.2% from the prior year.
• Goodwill for Q1 2026 stood at $16.7 million, roughly flat from $16.7 million in the prior quarter.
• The five-year high for Goodwill was $19.1 million in Q1 2023, with the low at $10.1 million in Q1 2022.
• Historically, Goodwill has averaged $15.3 million across 5 years, with a median of $16.5 million in 2023.
• Annual changes were most pronounced in 2022 — Goodwill surged 2031.09% — and 2024, when it decreased 15.46%.
• Cytek Biosciences' Goodwill stood at $10.1 million in 2022, then surged by 59.53% to $16.2 million in 2023, then grew by 2.97% to $16.7 million in 2024, then grew by 0.2% to $16.7 million in 2025, then declined by 0.05% to $16.7 million in 2026.
• The last three Goodwill figures came in at $16.7 million (Q1 2026), $16.7 million (Q4 2025), and $16.7 million (Q3 2025), per Business Quant data.